Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

ClinicalTrials.gov ID: NCT00920816

Public ClinicalTrials.gov record NCT00920816. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 2:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AG-013736 (AXITINIB) FOR THE TREATMENT OF METASTATIC RENAL CELL CANCER

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is designed to demonstrate that axitinib (AG-013736) is superior to sorafenib in delaying tumor progression in patients with metastatic renal cell cancer.

Study identification

NCT ID
NCT00920816
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
492 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 24, 2009
Primary completion
Jul 26, 2012
Completion
Apr 28, 2021
Last update posted
May 5, 2022

2009 – 2021

United States locations

U.S. sites
58
U.S. states
15
U.S. cities
42
Facility City State ZIP Site status
Advanced Medical Specialties Miami Florida 33143
Advanced Medical Specialties Miami Florida 33176
Illinois Cancer Specialists Arlington Heights Illinois 60005
Illinois Cancer Specialists Niles Illinois 60714
Indiana University Health Central Indiana Cancer Centers Carmel Indiana 46032
Indiana University Health Central Indiana Cancer Centers Fishers Indiana 46037
Indiana University Health Central Indiana Cancer Centers Greenfield Indiana 46140
Indiana University Health Central Indiana Cancer Centers Indianapolis Indiana 46219
Indiana University Health Central Indiana Cancer Centers Indianapolis Indiana 46227
Missouri Cancer Associates Columbia Missouri 65201
Nebraska Methodist Hospital Omaha Nebraska 68114
Comprehensive Cancer Centers of Nevada Henderson Nevada 89052
US Oncology West Region Henderson Nevada 89052
Comprehensive Cancer Centers of Nevada Henderson Nevada 89074
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89128
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89148
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169
Hematology-Oncology Associates of Northern NJ, PA Morristown New Jersey 07962
Hematology-Oncology Associates of Northern NJ, PA Parsippany New Jersey 07054
New York Oncology Hematology, PC Albany New York 12206
New York Oncology Hematology, PC Albany New York 12208
New York Oncology Hematology, PC Latham New York 12110
New York Oncology Hematology, PC Rexford New York 12148
New York Oncology Hematology, PC Troy New York 12180
Raleigh Hematology Oncology Associates Cary North Carolina 27518
Raleigh Hematology Oncology Associates Raleigh North Carolina 27607
Raleigh Hematology Oncology Associates Raleigh North Carolina 27614
Northwest Cancer Specialists, PC Portland Oregon 97213
Northwest Cancer Specialists, PC Portland Oregon 97225
Northwest Cancer Specialists, PC Portland Oregon 97227
Northwest Cancer Specialists, PC Tualatin Oregon 97062
Penn State Milton S. Hershey Medical Center, Penn State Cancer Institute Hershey Pennsylvania 17033-0850
Medical University of South Carolina University Hospital Charleston South Carolina 29425
Medical University of South Carolina Charleston South Carolina 29425
Texas Oncology- Amarillo Amarillo Texas 79106
Texas Oncology-Beaumont, Mamie McFaddin Ward Cancer Center Beaumont Texas 77702-1449
Texas Oncology- Bedford Bedford Texas 76022
Texas Oncology- Baylor Charles A. Sammons Cancer Center Dallas Texas 75246
Texas Oncology- Fort Worth 12th Avenue Fort Worth Texas 76104
Texas Oncology- Southwest Fort Worth Fort Worth Texas 76132
Investigational Products Center (lPC) Fort Worth Texas 76177
US Oncology Research and Clinical Pharmacy Fort Worth Texas 76177
Texas Oncology - Grapevine Grapevine Texas 76051
Cancer Care Centers of South Texas Kerrville Texas 78028
Texas Oncology- McAllen South Second Street McAllen Texas 78503
Texas Oncology- Midland Allison Cancer Center Midland Texas 79701
Cancer Care Centers of South Texas San Antonio Texas 78217
Cancer Care Centers of South Texas San Antonio Texas 78258-3912
Texas Oncology-Deke Slayton Cancer Center Webster Texas 77598-4420
Texas Oncology-Weslaco Weslaco Texas 78596
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Christiansburg Virginia 24073
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Low Moor Virginia 24457
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Roanoke Virginia 24014
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Salem Virginia 24153
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Wytheville Virginia 24382
Northwest Cancer Specialists, PC Vancouver Washington 98684
Northwest Cancer Specialists, PC Vancouver Washington 98686
Wenatchee Valley Medical Center Wenatchee Washington 98801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00920816, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2022 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00920816 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →